West Michigan Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

West Michigan Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,552	Closed	-$205K	–	250
2025 Q1	$205K	Buy	+1,552	New	+$193K	0.07%	205

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

West Michigan Advisors's ITCI Position: Q2 2025 in Review

West Michigan Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1,552 shares — an estimated $205K sold.

West Michigan Advisors first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $205K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

West Michigan Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
West Michigan Advisors sold 1,552 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $205K.
West Michigan Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
West Michigan Advisors's Intra-Cellular Therapies Inc. position peaked at $205K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on West Michigan Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.